![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 1, 112-116, Jan, 1991
WM Shafer, J Pohl, VC Onunka, N Bangalore and J Travis
Human neutrophil lysosomal cathepsin G (cat G) exerts broad-spectrum
antibacterial action in vitro against Gram-negative and -positive bacteria
independent of its serine protease activity. We recently determined that an
internal peptide of cat G (HPQYNQR), obtained after digestion of cat G with
clostripain, possessed broad-spectrum antibacterial action in vitro,
displaying an ED50 of 5 x 10(-5) M. In order to evaluate the
structure-antibacterial properties of this peptide, synthetic variants with
single alanine substitutions at each position were prepared and tested for
antibacterial action. We found that alanine substitution for His-1 or
Tyr-4, or certain modifications of the His-1 side chain, produced
nonbactericidal peptides. A hexapeptide lacking the COOH-terminal Arg-7 but
not a pentapeptide lacking both Gln-6 and Arg-7 possessed in vitro
bactericidal activity. Interestingly, the cat G bactericidal peptide
displays similarity to sequences within other serine proteases, notably the
proposed cytotoxic granzymes present in the cytolytic granules of human and
mouse cytotoxic T lymphocytes. We now report that an internal peptide of
one human granzyme (granzyme B) with the sequence of HPAYNPK also displays
bactericidal action in vitro. Our results suggest that an internal
antibacterial domain among human serine proteases cat G and granzyme B has
been functionally conserved through evolution perhaps for the purpose of
host defense against microbial pathogens and targets of cytotoxic T
lymphocyte killing.
Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide
Department of Microbiology and Immunology, Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia 30322.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Sieprawska-Lupa, P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, et al. Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4673 - 4679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Rivera-Marrero, J. Stewart, W. M. Shafer, and J. Roman The Down-Regulation of Cathepsin G in THP-1 Monocytes after Infection with Mycobacterium tuberculosis Is Associated with Increased Intracellular Survival of Bacilli Infect. Immun., October 1, 2004; 72(10): 5712 - 5721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wagner, C. Iking-Konert, B. Denefleh, S. Stegmaier, F. Hug, and G. M. Hansch Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils Blood, February 1, 2004; 103(3): 1099 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chicharro, C. Granata, R. Lozano, D. Andreu, and L. Rivas N-Terminal Fatty Acid Substitution Increases the Leishmanicidal Activity of CA(1-7)M(2-9), a Cecropin-Melittin Hybrid Peptide Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2441 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. MacIvor, S. D. Shapiro, C. T.N. Pham, A. Belaaouaj, S. N. Abraham, and T. J. Ley Normal Neutrophil Function in Cathepsin G-Deficient Mice Blood, December 15, 1999; 94(12): 4282 - 4293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rehault, M. Brillard-Bourdet, M. A. Juliano, L. Juliano, F. Gauthier, and T. Moreau New, Sensitive Fluorogenic Substrates for Human Cathepsin G Based on the Sequence of Serpin-reactive Site Loops J. Biol. Chem., May 14, 1999; 274(20): 13810 - 13817. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Rosenberg and H. F. Rosenberg Recombinant Human Eosinophil Cationic Protein J. Biol. Chem., April 7, 1995; 270(14): 7876 - 7881. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |